tmmonline.nz  |   landlords.co.nz        About Good Returns  |  Advertise  |  Contact Us  |  Terms & Conditions  |  RSS Feeds

NZ's Financial Adviser News Centre

GR Logo
Last Article Uploaded: Tuesday, March 19th, 10:57AM

Investments

rss
Investment News

Measuring the pulse of Calan's fees

Calan Healthcare Property Trust has been criticised about the high level of its fees. Jenny Ruth investigates to see if they really are high.

Tuesday, September 24th 2002, 8:59PM

by Jenny Ruth

The Calan Healthcare Properties Trust has been widely criticised in the past for its high management fees, intensified because much of its development work is done in-house so that element of this year’s annual report, due out later this week, is sure to receive much attention.

Its fees are certainly comparatively high. Last year, its management expense ratio (MER), the total of all costs excluding interest and a small foreign currency loss, added up to 18.4% of revenue.

While that was down from 22.9% of revenue in the previous year, it still compares very poorly with other listed property trusts. Kiwi Income Property Trust, for example had a MER of 11.3% in the year ended March and 11.8% in the previous year.

The comparison isn’t entirely fair as Kiwi is much bigger with total assets of $880 million and consequently has significant economies of scale compared with Calan’s $213.2 million.

When Calan reported its results at the end of August, it said its overall expenses were down 10.7% because it paid less interest. Its pre-tax profit was up 18.3% at $10.6 million, although a higher tax bill cut the bottom line increase to 4.8% at $9.1 million. But what of this year’s MER?

Chief operating officer Miles Wentworth says the annual report will show Calan’s MER is continuing to fall and was only 15.74% of revenue in the latest year.

He also says that property trust MERs aren’t directly comparable because of differing accounting practices in different companies.

It’s "absolutely unfair" to make comparisons unless you’re comparing apples with apples, he says.

"We believe we’re probably the most explicit in what we do in the market place. Maybe that in itself creates criticism," Wentworth says.

While the Shareholders’ Association is taking a close look at Calan’s fees, analysts say investors shouldn’t look at them in isolation.

One reason Calan’s fees are so high is that a lot of the work associated with its developments is done in-house and that in such a specialist field outside experts are mostly not available.

"There’s not a lot of expertise in the design of health properties in New Zealand. These guys have built up a lot of internal expertise," says one analyst

Wentworth says the company would prefer to have external parties doing the work. "It adds an additional risk from the management company’s perspective," he says.

Another analyst says the amount of Calan’s fees isn’t really the issue. "I don’t care about paying for performance," and that’s where Calan has fallen down in the past because of development delays.

But those problems are reflected in the current unit price, 80 cents, which probably fairly prices the company, he says. That’s down from near $1.20 in early 2000. "The market’s sent the company a bit of a message. Until they get runs on the board, that’s the way it’s going to stay."

Net asset backing per unit at 30 June was $1.09.

One factor in management’s favour has been its readiness to sell properties, he says.

The company sold $23.4 million worth of property last year, at mostly slightly more than book value, and has sold a further $2.7 million since 30 June.

"I encourage companies to recycle their capital but not many do because the game has been growing funds under management," the analyst says.

Another encouraging sign for investors is that the gross distribution rose this year from 6.8 cents a unit to 7.5 cents after years of declines.

« Market review: Not out of the woods yetKing builds an empire »

Special Offers

Commenting is closed

 

print

Printable version  

print

Email to a friend

Good Returns Investment Centre is brought to you by:

Subscribe Now

Keep up to date with the latest investment news
Subscribe to our newsletter today

Edison Investment Research
  • Electra Private Equity
    27 September 2021
    Introducing Hostmore and Unbound brands
    On 16 September, Electra Private Equity (ELTA) issued a trading update for its largest remaining hospitality brands, Fridays and 63rd+1st, and named the...
  • European Assets Trust
    21 September 2021
    Performance, income and a well-balanced portfolio
    European Assets Trust (EAT) aims to achieve long-term growth of capital through investments in smaller European companies (excluding the UK). EAT’s...
  • Georgia Capital
    13 September 2021
    Value creation on the back of macro recovery
    Georgia Capital (GCAP) posted a 13.2% NAV total return (TR) in local currency terms in H121 (15.2% in sterling), driven by an improved operating performance...
© 2024 Edison Investment Research.

View more research papers »

Today's Best Bank Rates
Rabobank 5.25  
Based on a $50,000 deposit
More Rates »
About Us  |  Advertise  |  Contact Us  |  Terms & Conditions  |  Privacy Policy  |  RSS Feeds  |  Letters  |  Archive  |  Toolbox  |  Disclaimer
 
Site by Web Developer and eyelovedesign.com